Difference between revisions of "Adenocarcinoma in situ"
Jump to navigation
Jump to search
(+descript) |
|||
| Line 1: | Line 1: | ||
[[Image:Endocervical adenocarcinoma in situ --- high mag.jpg|thumb|right|[[Endocervical AIS]]. [[H&E stain]]. (WC/Nephron)]] | [[Image:Endocervical adenocarcinoma in situ --- high mag.jpg|thumb|right|[[Endocervical AIS]] (right of image) and benign endocervical mucosa (left of image). [[H&E stain]]. (WC/Nephron)]] | ||
'''Adenocarcinoma in situ''', abbreviated '''AIS''', refers to a non-invasive gland-forming neoplasm. | '''Adenocarcinoma in situ''', abbreviated '''AIS''', refers to a non-invasive gland-forming neoplasm. | ||
Latest revision as of 14:54, 5 June 2016
Endocervical AIS (right of image) and benign endocervical mucosa (left of image). H&E stain. (WC/Nephron)
Adenocarcinoma in situ, abbreviated AIS, refers to a non-invasive gland-forming neoplasm.
It often refers to:
It may refer to:
- Adenocarcinoma in situ of the urinary bladder - see adenocarcinoma of the urinary bladder.
- Adenocarcinoma in situ of the lung.
- Not diagnosed on small biopsies.[1]
See also
References
- ↑ Travis WD, Brambilla E, Noguchi M, et al. (February 2011). "International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma". J Thorac Oncol 6 (2): 244–85. doi:10.1097/JTO.0b013e318206a221. PMID 21252716.